Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $17 | $15 | $14 | $14 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $17 | $15 | $14 | $14 |
| Revenue | $1 | $2 | $2 | $2 |
| % Growth | -27.2% | 10.7% | -3.3% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 41.4% | 60.3% | 59.5% | 61.7% |
| EBITDA | $1 | $0 | $0 | $1 |
| % Margin | 51.1% | 20.9% | 27.3% | 36.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 29.5% | 7.5% | 15.8% | 22.9% |
| EPS Diluted | 0.64 | 0.23 | 0.43 | 0.65 |
| % Growth | 178.3% | -46.5% | -33.8% | – |
| Operating Cash Flow | $1 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |